<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE311nnn/GSE311396/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311396</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>NELFA-mediated promoter-proximal pausing restrains YAP-driven transcription and shapes context-dependent outcomes in breast cancer</name><description>Overexpression of YAP is associated with oncogenesis and tumor progression in multiple malignancies. YAP is the key transcriptional effector of a highly conserved Hippo signaling pathway, from Drosophila (Yki) to humans (YAP). In our previous Drosophila screen, we identified NELFA, a core component of the promoter-proximal pausing (PPP) complex, as a suppressor of Yki-driven hyperproliferation. Building on this observation, we investigated whether this PPP–YAP regulatory interaction is conserved in mammalian cells, using breast cancer as a model system. Using HEK293T and MDA-MB-231 cells, we demonstrate that NELFA depletion selectively amplifies YAP-driven transcription, thereby enhancing the expression of canonical YAP target genes. Whole-transcriptome analysis of NELFA-depleted MDA-MB-231 cells revealed widespread reprogramming upon NELFA loss, with strong enrichment of conserved YAP signatures, EMT and TGF-β pathways, and AP-1/TEAD-SMAD3 transcriptional networks—indicating that NELFA regulates a broad YAP-centered oncogenic module. Clinical analysis of an Indian breast cancer cohort and TCGA revealed a striking context-dependent role for NELFA. Low NELFA expression predicted poor disease-free survival in YAP-high tumors—particularly in triple-negative breast cancer (TNBC)—suggesting a tumor-suppressive role. While High NELFA expression correlated with poorer overall survival. Collectively, these findings reveal that NELFA’s role in YAP-driven transcription is context-dependent in the breast cancer setting.</description><dates><publication>2026/05/15</publication></dates><accession>GSE311396</accession><cross_references><GSM>GSM9324449</GSM><GSM>GSM9324445</GSM><GSM>GSM9324456</GSM><GSM>GSM9324446</GSM><GSM>GSM9324447</GSM><GSM>GSM9324448</GSM><GSM>GSM9324452</GSM><GSM>GSM9324453</GSM><GSM>GSM9324454</GSM><GSM>GSM9324455</GSM><GSM>GSM9324450</GSM><GSM>GSM9324451</GSM><GPL>34284</GPL><GSE>311396</GSE><taxon>Homo sapiens</taxon><PMID>[42100387]</PMID></cross_references></HashMap>